Jazz Pharmaceuticals PLC (JAZZ) Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing Oncology Research at AACR 2026
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) FY 2026 Other Release
23 articles, transcripts, and reports
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) FY 2026 Other Release
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q4 2025 Earnings Call dated Feb. 24, 2026 Corporate Participants: John Bluth — Head of...
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Sec Form 10K
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Sec Form 8K
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q4 2025 Earnings Release
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) FY 2026 Corporate Conference
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) FY 2026 Corporate Conference
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q4 2025 Earnings Conference
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q4 2025 Earnings Announcement
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q2 2025 Earnings Call dated Aug. 05, 2025 Corporate Participants: Jack Spinks — Investor Relations Bruce Cozadd — Chief Executive…